Cite
HARVARD Citation
Viglietta, V. et al. (n.d.). [P1–053]: CHANGE FROM BASELINE IN CLINICAL DEMENTIA RATING SCALE COGNITIVE AND FUNCTIONAL DOMAINS IN PRIME, A RANDOMIZED PHASE 1B STUDY OF THE ANTI–AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB (BIIB037). Alzheimer's & dementia. pp. P256-P257. [Online].